
CIT GAP Funds invests in Biotherapeutics Inc.
The Center for Innovative Technology (CIT) announced that its CIT GAP Funds closed an investment in Biotherapeutics, Inc., a Blacksburg-based company advancing therapeutics to treat inflammation and diabetes.

